Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Will The Drug Formulation Market Valuation Change Between Now And 2029?

The pharmaceutical formulation market has seen a robust expansion in the past few years. The market size is projected to increase from $1908.89 billion in 2024 to $2045.31 billion in 2025, with a compound annual growth rate (CAGR) of 7.1%. Factors such as biopharmaceutical advancements, development of drugs focused on individual patients, personalized healthcare, regulatory backing for rare disease drugs and heightened research and development investments have contributed to this historic growth.

Expectations are high for a substantial increase in the drug formulation market size in the coming years, which is projected to rise to $2894.29 billion in 2029 with a compound annual growth rate (CAGR) of 9.1%. This predicted growth during the forecast period is due to advancements in fields such as 3D printing, pediatric formulations, biological drug delivery systems, green chemistry in formulation, and the use of artificial intelligence (AI). Additionally, key trends during this forecast period are anticipated to be the dominance of biopharmaceuticals and biologics, the use of advanced drug delivery systems, the move towards personalized medicine and individualized formulations, the application of nanotechnology, and a focus on lifecycle management and reformulation strategies.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9900&type=smp

What Market Forces Are Contributing To The Growth Of The Drug Formulation Market?

The projected increase in chronic diseases is anticipated to drive the growth of the drug formulation market. Chronic diseases, which are conditions that persist for at least a year and require continuous medical care or limit daily activities, can potentially be reduced through drug formulation. This involves the use of multiple drug delivery methods to achieve the best therapeutic effectiveness while reducing negative side effects by affecting how medication is absorbed, distributed, metabolized, and excreted. For example, a September 2022 report from the National Institutes of Health (NIH), a biomedical research agency in the US, predicted that by 2023, the number of individuals aged 50 years and above in the US with at least one chronic illness will surge by 99.5% from 71.52 million in 2020 to 142.66 million in 2050. Furthermore, the population experiencing multimorbidity is expected to grow by 91.16% from 7.8304 million in 2020 to 14.968 million in 2050. Therefore, the increasing prevalence of chronic diseases is a key driver for the expansion of the drug formulation market.

What Segmentation Insights Are Provided In The Drug Formulation Market Research?

The drug formulation market covered in this report is segmented –

1) By Dosage Form: Oral formulations, Parenteral Formulations, Topical Formulations, Inhalation Formulations

2) By Formulation: Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Other Formulations

3) By Therapy Area: Cardiovascular Diseases (CVDs), Pain, Diabetes, Cancer, Respiratory Diseases, Other Diseases

4) By End-User: Big Pharma, Small And Medium Pharma, Biotech Companies

Subsegments:

1) By Oral Formulations: Tablets, Capsules, Powders, Liquids Or Solutions

2) By Parenteral Formulations: Injectables, Implants, Infusions

3) By Topical Formulations: Creams, Ointments, Gels, Transdermal Patches

4) By Inhalation Formulations: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

Which Notable Trends Are Transforming The Drug Formulation Market Outlook?

The rise in technological innovation is a crucial trend that’s making an impact in the drug formulation sector. Major entities functioning in this market are focusing their resources on integrating modern and innovative technologies to fortify their dominance in the industry. For instance, in June 2022, the US-based pharmaceutical firm, Merck & Co., Inc., has initiated the Merck Digital Sciences Studio (MDSS) with the aim to develop ground-breaking technologies for pharmaceutical research and development. Through utilizing Azure Cloud’s robust computing capabilities and Merck’s own discovery and clinical expertise, they collectively hasten the advancement and adoption of cutting-edge digital technologies. MDSS is a cooperative venture between Merck and the New Jersey Innovation Institute (NJII), a US-based entity affiliated with the New Jersey Institute of Technology. The project has received financial backing from the Merck Global Health Innovation Fund, Northpond Ventures, and McKesson Ventures, with Microsoft providing technological assistance to start-up firms.

Which Companies Are Contributing Significantly To The Drug Formulation Market Growth?

Major companies operating in the drug formulation market include AstraZeneca PLC, The Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., AbbVie Inc., C.H. Boehringer Sohn AG & Co. KG, F. Hoffmann-La Roche AG, Johnson & Johnson, Bayer AG, Teva Pharmaceutical Industries Ltd., Sanofi S.A., GlaxoSmithKline plc, Novo Nordisk A/S, Amgen Inc., Viatris Inc., Sandoz International GmbH, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Limited, Torrent Pharmaceuticals Limited, Jubilant Life Sciences Limited, Cadila Healthcare Limited, Glenmark Pharmaceuticals Ltd., Wockhardt Ltd., Hikma Pharmaceuticals plc

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/drug-formulation-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Drug Formulation Market?

North America was the largest region in the drug formulation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug formulation market report during the forecast period. The regions covered in the drug formulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=9900&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model